Actively Recruiting
Remote Monitoring of COPD Patients Experiencing an Acute Exacerbation Through Health Evaluations Using Wearable Mobile Technology
Led by David Ruttens · Updated on 2026-03-04
50
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic obstructive pulmonary disease (COPD) is a serious lung condition causing about three million deaths each year and creating a heavy burden on healthcare systems, especially in Europe where costs reach 38.6 billion euros annually. Frequent flare-ups called acute exacerbations of COPD (AECOPD) worsen health, speed lung decline, and reduce quality of life. These flare-ups often occur outside hospitals and are hard to prevent, making early detection very important to reduce hospitalizations and improve patient outcomes. This trial studies the use of a wearable mobile device to monitor COPD patients remotely after they are admitted to the emergency room with an acute exacerbation. The device tracks physical activity, heart rate, breathing rate, oxygen saturation (SpO2), sleep, and skin temperature continuously from hospital admission until three months after discharge or rehospitalization. Participants will also complete questionnaires about their health and readiness to use digital tools. This monitoring aims to help build a model that predicts worsening of COPD symptoms early. Participants will wear the device and use a linked app on their smartphone to send vital data to the researchers. They will complete assessments including the COPD Assessment Test and a digital health readiness questionnaire at admission and study end. Researchers will measure how well vital signs stabilize and how closely patients follow the monitoring plan over three months. The study will help understand disease progression after an exacerbation and support development of timely interventions to prevent hospital stays.
CONDITIONS
Brief Title
Remote Monitoring of COPD Patients Experiencing an Acute Exacerbation Through Health Evaluations Using Wearable Mobile Technology
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Provide signed and dated informed consent
- Adults older than 18 years of age
- Previously diagnosed with COPD
- Speak and understand the Dutch language
- Need for hospitalization
You will not qualify if you...
- Previous diagnosis of asthma
- Not in the possession of a smartphone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during hospital admission
Duration - 3 months
Participants wear a wearable mobile device to remotely monitor vital parameters including physical activity, heart rate, respiratory rate, oxygen saturation, sleep patterns, and core body temperature following admission for an acute COPD exacerbation.
Continuous monitoring with device usage throughout the period
Duration - At end of 3 months
Participants complete COPD Assessment Test questionnaires at the end of the monitoring period to assess changes in symptoms and health status.
1 visit (in-person or remote) at study completion
Trial Site Locations
Total: 1 location
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600
Actively Recruiting
Research Team
R
Ruben Knevels, MSc
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here